WW International Inc
NASDAQ:WW

Watchlist Manager
WW International Inc Logo
WW International Inc
NASDAQ:WW
Watchlist
Price: 19.55 USD -3.93% Market Closed
Market Cap: $195.3m

WW International Inc
Investor Relations

WW International, Inc. engages in the provision of weight management services. The company is headquartered in New York City, New York and currently employs 7,700 full-time employees. The company went IPO on 2001-11-15. The firm offers digital subscription products based on the WW approach to wellness and weight management. Its products provide interactive and personalized resources that allow users to follow its weight management program via its application and Web-based products. The company operates through four geographical segments: North America, Continental Europe (CE), United Kingdom, and Other. The firm's digital business refers to providing subscriptions to its digital product offerings, including Digital 360, and Personal Coaching + Digital. Its Workshops + Digital business provides unlimited access to its workshops combined with its digital subscription product offerings to commitment plan subscribers. The company also includes the provision of access to workshops for members who do not subscribe to commitment plans, including its pay-as-you-go members. Its digital offerings are also provided through workshops, and various events and experiences.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q3 2025
Call Date
Nov 6, 2025
AI Summary
Q3 2025

Revenue & Profitability: Q3 revenue was $172 million, down 11% year-over-year, but adjusted EBITDA margin remained strong at nearly 25%.

Guidance Raised: Full-year 2025 revenue guidance was narrowed to the high end of the previous range, now $695–700 million, and adjusted EBITDA guidance to $145–150 million.

Subscriber Trends: Behavioral subscribers declined 20% YoY to 2.9 million, but clinic subscribers rose 60% to 124,000, with Q3 expected to be the low point for clinic subscribers.

GLP-1 Growth: Clinical revenue jumped 35% YoY, fueled by GLP-1 medication demand and successful transition from compounded to branded medications.

Product Transformation: Major digital overhaul underway—new app and website launching early next year, aiming for seamless integration of behavioral and clinical programs.

Brand Repositioning: Comprehensive brand refresh and shift to value-based pricing and full-funnel marketing to drive new growth and change market perception.

Operational Efficiency: Continued cost discipline and automation efforts, including AI-driven customer support, delivering significant run-rate savings.

Key Financials
Revenue
$172 million
Adjusted EBITDA
$43 million
Adjusted EBITDA Margin
24.9%
Behavioral Subscribers (End of Period)
2.9 million
Clinical Subscribers (End of Period)
124,000
Monthly ARPU
$18.52
Adjusted Gross Margin
75.1%
Marketing Expense
28% of revenue
Cash and Cash Equivalents
$170 million
Capital Expenditures
$3 million
Cash Flow from Operations
use of $3 million
Earnings Call Recording
Other Earnings Calls

Management

Ms. Tara M. Comonte
Interim CEO & Director
No Bio Available
Ms. Heather Stark C.P.A.
Chief Financial Officer
No Bio Available
Ms. Nicole Haag
Corporate Controller & Principal Accounting Officer
No Bio Available
Mr. Gary D. Foster Ph.D.
Chief Scientific Officer
No Bio Available
Ms. Jacqueline Cooke
General Counsel & Secretary
No Bio Available
Ms. Tiffany Stevenson
Chief People Officer
No Bio Available
Ms. Debra Benovitz
Chief Insights Officer
No Bio Available
Mr. David Cohen
Chief Data Officer
No Bio Available
Mr. Tony Yen
Head of Taiwan
No Bio Available
Ms. Amy Meister D.O.
Chief Medical Officer
No Bio Available

Contacts

Address
NEW YORK
New York City
675 Avenue of the Americas Fl 6
Contacts
+12125892700.0
corporate.ww.com